Similar articles

• ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.

  Li X, Shang D, Shen H, Song J, Hao G, Tian Y. Li X, et al. Biomed Pharmacother. 2020 Jun;126:110066. doi: 10.1016/j.biopha.2020.110066. Epub 2020 Mar 12. Biomed Pharmacother. 2020. PMID: 32172065
• Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].

  Ni T, Wang H, Li D, Tao L, Lv M, Jin F, Wang W, Feng J, Qian Y, Sunagawa M, Liu Y. Ni T, et al. Biomed Pharmacother. 2020 Mar;123:109823. doi: 10.1016/j.biopha.2020.109823. Epub 2020 Jan 17. Biomed Pharmacother. 2020. PMID: 31959384 No abstract available.
• Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 2020 (128) 110366].

  Guo Y, Zhu H, Weng M, Chen B, Wang C, Sun L. Guo Y, et al. Biomed Pharmacother. 2020 Oct;130:110631. doi: 10.1016/j.biopha.2020.110631. Epub 2020 Aug 19. Biomed Pharmacother. 2020. PMID: 32828598 No abstract available.
• Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 128 (2020) 110366].

  Guo Y, Zhu H, Weng M, Chen B, Wang C, Sun L. Guo Y, et al. Biomed Pharmacother. 2020 Sep;129:110394. doi: 10.1016/j.biopha.2020.110394. Epub 2020 Jun 17. Biomed Pharmacother. 2020. PMID: 32561180 No abstract available.
• Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790].

  Cai H, Yan L, Liu N, Xu M, Cai H. Cai H, et al. Biomed Pharmacother. 2020 Jun;126:110077. doi: 10.1016/j.biopha.2020.110077. Epub 2020 Mar 12. Biomed Pharmacother. 2020. PMID: 32173085 No abstract available.